• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

孕期甲状腺疾病筛查:缅因州一项调查的结果

Screening for thyroid disorders during pregnancy: results of a survey in Maine.

作者信息

Haddow James E, McClain Monica R, Palomaki Glenn E, Kloza Edward M, Williams Josephine

机构信息

Foundation for Blood Research, Scarborough, ME, USA.

出版信息

Am J Obstet Gynecol. 2006 Feb;194(2):471-4. doi: 10.1016/j.ajog.2005.07.055.

DOI:10.1016/j.ajog.2005.07.055
PMID:16458648
Abstract

OBJECTIVE

Guidelines regarding prenatal screening for thyroid deficiency are conflicting, and current practice in primary care settings is unknown. Our survey sought to determine the: 1) extent of screening in Maine; 2) factors associated with screening; and 3) laboratory cut-off levels used.

STUDY DESIGN

In 2004 we surveyed 61 prenatal care practices, representing 246 practitioners and 85% of Maine deliveries.

RESULTS

Screening via thyroid-stimulating hormone (TSH) testing was routine in 48% of the practices. Obstetrician practices screened at a significantly higher rate than family practices (56% vs 8%; odds ratio [OR] 15.0, 95% CI 1.9-130.0). Nonsignificant higher rates were found for urban versus rural, and multipractitioner versus solo practices. The lower TSH cut-off levels ranged between 0.1 and 0.5 mU/L among practices; the upper cut-off levels ranged between 3.5 and 5.5 mU/L.

CONCLUSION

Prenatal screening for thyroid deficiency varies among practices, reflecting conflicting guidelines. TSH cut-offs are also variable and might benefit from standardization.

摘要

目的

关于甲状腺功能减退症产前筛查的指南存在冲突,目前基层医疗环境中的实际做法尚不清楚。我们的调查旨在确定:1)缅因州的筛查范围;2)与筛查相关的因素;3)所使用的实验室临界值水平。

研究设计

2004年,我们对61家产前护理机构进行了调查,这些机构代表了246名从业者以及缅因州85%的分娩情况。

结果

48%的机构常规通过促甲状腺激素(TSH)检测进行筛查。产科机构的筛查率显著高于家庭医疗机构(56%对8%;优势比[OR]15.0,95%可信区间1.9 - 130.0)。城市与农村、多从业者机构与单从业者机构之间的筛查率虽有差异但不显著。各机构中较低的TSH临界值水平在0.1至0.5 mU/L之间;较高的临界值水平在3.5至5.5 mU/L之间。

结论

甲状腺功能减退症的产前筛查在不同机构中存在差异,这反映了相互冲突的指南。TSH临界值也各不相同,标准化可能会有所助益。

相似文献

1
Screening for thyroid disorders during pregnancy: results of a survey in Maine.孕期甲状腺疾病筛查:缅因州一项调查的结果
Am J Obstet Gynecol. 2006 Feb;194(2):471-4. doi: 10.1016/j.ajog.2005.07.055.
2
Sexually transmitted diseases during pregnancy: screening, diagnostic, and treatment practices among prenatal care providers in Georgia.
South Med J. 2001 Jan;94(1):47-53.
3
Diagnosing and managing thyroid disorders during pregnancy: a survey of obstetrician-gynecologists.孕期甲状腺疾病的诊断与管理:妇产科医生的一项调查
J Reprod Med. 2004 Feb;49(2):79-82.
4
Screening for HIV during pregnancy. Survey of physicians' practices.孕期HIV筛查。医生实践调查。
Can Fam Physician. 2001 Nov;47:2250-7.
5
What are the barriers to offering HIV testing in an antenatal setting? A national study of obstetricians.在产前环境中提供艾滋病毒检测存在哪些障碍?一项针对产科医生的全国性研究。
AIDS. 2007 Jul 31;21(12):1601-6. doi: 10.1097/QAD.0b013e32823ecf45.
6
Do general practitioners use thyroid stimulating hormone assay for opportunistic screening?全科医生是否会使用促甲状腺激素检测进行机会性筛查?
N Z Med J. 2009 Aug 21;122(1301):25-30.
7
Needs assessment and current practice of alcohol risk assessment of pregnant women and women of childbearing age by primary health care professionals.初级卫生保健专业人员对孕妇和育龄妇女进行酒精风险评估的需求评估及当前实践。
Can J Clin Pharmacol. 2008 Summer;15(2):e214-22. Epub 2008 Jun 1.
8
Can you use a sequential sample of patients as a substitute for a full practice audit?: Study of mammography screening rates in 20 family practices in Ontario.你能否使用患者的连续样本替代全面的执业审计?安大略省20家家庭诊所的乳房X光检查筛查率研究。
Can Fam Physician. 2008 Oct;54(10):1436-7, 1437.e1-5.
9
Factors associated with open practices: results from the Canadian National Family Physician Survey.与开放医疗行为相关的因素:来自加拿大国家家庭医生调查的结果。
Can Fam Physician. 2006 Jan;52(1):66-7.
10
Emergency department sexually transmitted disease and human immunodeficiency virus screening: findings from a national survey.急诊科性传播疾病和人类免疫缺陷病毒筛查:一项全国性调查的结果
Acad Emerg Med. 2006 Sep;13(9):993-6. doi: 10.1197/j.aem.2006.04.017. Epub 2006 Aug 7.

引用本文的文献

1
Screening for thyroid disease in pregnancy: a study of Danish clinical practice.孕期甲状腺疾病筛查:丹麦临床实践研究
Thyroid Res. 2023 Mar 31;16(1):9. doi: 10.1186/s13044-023-00151-x.
2
Prepregnancy Hypothyroidism versus Gestational Hypothyroidism: A Comparative Study.孕前甲状腺功能减退与妊娠期甲状腺功能减退:一项比较研究。
Indian J Endocrinol Metab. 2017 Sep-Oct;21(5):660-664. doi: 10.4103/ijem.IJEM_158_17.
3
Risk factors and a clinical prediction model for low maternal thyroid function during early pregnancy: two population-based prospective cohort studies.
孕早期母体甲状腺功能低下的危险因素及临床预测模型:两项基于人群的前瞻性队列研究
Clin Endocrinol (Oxf). 2016 Dec;85(6):902-909. doi: 10.1111/cen.13153. Epub 2016 Aug 15.
4
2014 European thyroid association guidelines for the management of subclinical hypothyroidism in pregnancy and in children.2014 年欧洲甲状腺协会妊娠和儿童亚临床甲状腺功能减退症管理指南。
Eur Thyroid J. 2014 Jun;3(2):76-94. doi: 10.1159/000362597. Epub 2014 Jun 7.
5
Five-year follow-up for women with subclinical hypothyroidism in pregnancy.妊娠亚临床甲状腺功能减退症妇女的 5 年随访。
J Clin Endocrinol Metab. 2013 Dec;98(12):E1941-5. doi: 10.1210/jc.2013-2768. Epub 2013 Nov 11.
6
Screening for maternal thyroid dysfunction in pregnancy: a review of the clinical evidence and current guidelines.孕期母体甲状腺功能障碍的筛查:临床证据与现行指南综述
J Thyroid Res. 2013;2013:851326. doi: 10.1155/2013/851326. Epub 2013 May 20.
7
Thyroid disorders in pregnancy.妊娠与甲状腺疾病。
Nat Rev Endocrinol. 2012 Nov;8(11):650-8. doi: 10.1038/nrendo.2012.171. Epub 2012 Sep 25.
8
Thyroid testing during pregnancy at an academic Boston Area Medical Center.在波士顿学术医疗中心的孕期甲状腺检测。
J Clin Endocrinol Metab. 2011 Sep;96(9):E1452-6. doi: 10.1210/jc.2011-0360. Epub 2011 Jun 29.
9
The role of clinical guidelines in patient care: thyroid hormone replacement in women of reproductive age.临床指南在患者护理中的作用:育龄妇女的甲状腺激素替代治疗。
Thyroid. 2010 Mar;20(3):301-7. doi: 10.1089/thy.2009.0321.
10
Gender is an age-specific effect modifier for papillary cancers of the thyroid gland.性别是甲状腺乳头状癌的一个年龄特异性效应修饰因素。
Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1092-100. doi: 10.1158/1055-9965.EPI-08-0976. Epub 2009 Mar 17.